1097870-73-9

Basic information

• Product Name: methyl 2-(4-cyclopropylphenyl)acetate
• Synonyms: methyl 2-(4-cyclopropylphenyl)acetate
• CAS NO: 1097870-73-9
• Molecular Weight: 190.242
• Mol File: 1097870-73-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 2-(4-cyclopropylphenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(4-cyclopropylphenyl)acetate(1097870-73-9)
• EPA Substance Registry System: methyl 2-(4-cyclopropylphenyl)acetate(1097870-73-9)

Safety Data

• Hazardous Substances Data: 1097870-73-9(Hazardous Substances Data)

Upstream product

• 16532-79-9 4-Bromophenylacetonitrile 
• 63349-52-0 methyl 4-iodophenylacetate 
• 411235-57-9 cyclopropylboronic acid 
• 67-56-1 methanol 
• 893738-65-3 2-(4-cyclopropylphenyl)acetonitrile 

Downstream Products

• 40641-90-5 2-(4-cyclopropylphenyl)acetic acid 
• 1334783-34-4 7-[(4-cyclopropylphenyl)acetyl]-2-(5-pyrimidin-2-yl-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonane 
• 1334783-35-5 (R)-7-[(4-cyclopropylphenyl)acetyl]-2-(5-pyrimidin-2-yl-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonane 

Relevant articles and documents

COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND VEMURAFENIB, AND METHODS OF USE

The invention provides a combination of a) a compound of Formula Ia: [insert Formula Ia], or a pharmaceutically acceptable salt thereof, and b) vemurafenib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hy

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds of Formula (I), including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.